Department of Physics, University of Trento, Via Sommarive 14, 38123, Trento, Italy.
INFN-TIFPA, Trento Institute for Fundamental Physics and Applications, 38123, Trento, Italy.
Sci Rep. 2021 Dec 1;11(1):23197. doi: 10.1038/s41598-021-02323-x.
The affinity of an antibody for its antigen is primarily determined by the specific sequence and structural arrangement of the complementarity-determining regions (CDRs). Recent evidence, however, points toward a nontrivial relation between the CDR and distal sites: variations in the binding strengths have been observed upon mutating residues separated from the paratope by several nanometers, thus suggesting the existence of a communication network within antibodies, whose extension and relevance might be deeper than insofar expected. In this work, we test this hypothesis by means of molecular dynamics (MD) simulations of the IgG4 monoclonal antibody pembrolizumab, an approved drug that targets the programmed cell death protein 1 (PD-1). The molecule is simulated in both the apo and holo states, totalling 4 μs of MD trajectory. The analysis of these simulations shows that the bound antibody explores a restricted range of conformations with respect to the apo one, and that the global conformation of the molecule correlates with that of the CDR. These results support the hypothesis that pembrolizumab featues a multi-scale hierarchy of intertwined global and local conformational changes. The analysis pipeline developed in this work is general, and it can help shed further light on the mechanistic aspects of antibody function.
抗体对其抗原的亲和力主要由互补决定区(CDR)的特定序列和结构排列决定。然而,最近的证据表明 CDR 与远端位点之间存在着复杂的关系:在突变与抗原结合部位相隔几个纳米的残基时,观察到结合强度的变化,这表明抗体内部存在一个通讯网络,其延伸和相关性可能比迄今为止预期的更深。在这项工作中,我们通过对 IgG4 单克隆抗体 pembrolizumab 的分子动力学(MD)模拟来检验这一假设,pembrolizumab 是一种针对程序性细胞死亡蛋白 1(PD-1)的已批准药物。该分子在apo 和 holo 两种状态下进行模拟,总模拟轨迹为 4 μs。这些模拟的分析表明,与 apo 状态相比,结合抗体在构象上只探索了一个受限的范围,并且分子的整体构象与 CDR 的构象相关。这些结果支持了 pembrolizumab 具有多层次的全局和局部构象变化相互交织的假说。本文开发的分析管道具有通用性,可以帮助进一步阐明抗体功能的机制方面。